Literature DB >> 2548792

Sulindac-induced aseptic meningitis in mixed connective tissue disease.

Y Yasuda1, I Akiguchi, M Kameyama.   

Abstract

A 21-year-old female with mixed connective tissue disease (MCTD) experienced nausea, headache, consciousness disturbance, nuchal rigidity, and a temperature of 38.5 less than or equal to C three days after the intake of sulindac (300 mg/day). Cerebrospinal fluid analysis revealed an opening pressure of 310 mm of water, a predominantly lymphocytic pleocytosis, and elevated protein content of 89 mg/dl. After discontinuing sulindac, the aseptic meningitis improved in five days. In the acute stage, CT scan disclosed contrast enhancement in the cerebral hemispheres, which suggests that hypersensitivity may be involved in the pathogenesis of nonsteroidal antiinflammatory drug (NSAID) induced aseptic meningitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548792     DOI: 10.1016/0303-8467(89)90121-2

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  3 in total

Review 1.  Drug-induced aseptic meningitis: diagnosis and management.

Authors:  S Jolles; W A Sewell; C Leighton
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

2.  CNS Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs : Therapeutic Implications.

Authors:  A Morgan; D Clark
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

3.  Meningitis in mixed connective tissue disease complicated by herpes virus infection: case report.

Authors:  Edit Bodolay; Péter Diószeghy; József Demeter; Anikó Bányai; István Csipö; Gyula Szegedi; Zoltán Szekanecz
Journal:  Rheumatol Int       Date:  2004-02-18       Impact factor: 3.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.